This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Coty (COTY) Stock Down Despite Q3 Earnings Beat & Raised View
by Zacks Equity Research
Coty's (COTY) third-quarter fiscal 2022 results reflect higher earnings and revenues on growth across all regions and channels. However, rising inflation and supply pressure are headwinds.
Sysco (SYY) Beats on Q3 Earnings & Sales, Raises EPS View
by Zacks Equity Research
Sysco's (SYY) third-quarter fiscal 2022 results reflect increased top and bottom lines. The company benefits from its Recipe for Growth plan and efforts to manage cost inflation.
TreeHouse Foods (THS) Q1 Loss Narrower Than Expected, Stock Up
by Zacks Equity Research
TreeHouse Foods' (THS) Q1 results reflect high demand for private label consumption and solid pricing actions to counter inflation, while volumes bear the brunt of labor and supply-chain woes.
Looking for a Growth Stock? 3 Reasons Why Inter Parfums (IPAR) is a Solid Choice
by Zacks Equity Research
Inter Parfums (IPAR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Things to Note as Inter Parfums (IPAR) Lines Up for Q1 Earnings
by Zacks Equity Research
Inter Parfums' (IPAR) first-quarter 2022 performance is likely to reflect increased sales on growth of its largest and mid-sized brands.
Tyson Foods (TSN) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Tyson Foods' (TSN) second-quarter fiscal 2022 sales and earnings rise year over year on the back of gains across all the segments. Management raises fiscal 2022 sales view.
Post Holdings (POST) Stock Up More Than 5% Since Q2 Earnings
by Zacks Equity Research
Post Holdings' (POST) second-quarter fiscal 2022 results reflect higher earnings and sales. While buyouts and continued foodservice recovery have been upsides, elevated costs have been a concern.
Hain Celestial's (HAIN) Q3 Earnings Miss Mark, Sales Rise Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) reports weak performance in third-quarter fiscal 2022 on high inflations, supply-chain disruptions, ingredient and package shortages.
B&G Foods (BGS) Q1 Earnings Miss Estimates, EPS View Lowered
by Zacks Equity Research
B&G Foods' (BGS) first-quarter fiscal 2022 results reflect gains from high demand and pricing actions, whereas the escalated input cost inflation hurts margins.
Kellogg's (K) Q1 Earnings Top Estimates, Organic Sales View Up
by Zacks Equity Research
Kellogg Company's (K) first-quarter 2022 results reflect higher sales, thanks to strength in snacks and solid price/mix. Earnings were hurt by increased cost inflation and other business hurdles.
Hostess Brands (TWNK) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Hostess Brands (TWNK) delivered earnings and revenue surprises of 17.39% and 9.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Medifast (MED) Tops Q1 Earnings & Sales Estimates, Raises View
by Zacks Equity Research
Medifast's (MED) first-quarter 2022 results reflect increased earnings and revenues owing to continued strength in OPTAVIA. Management raises sales and earnings view for 2022.
The Estee Lauder Companies (EL) Beats on Earnings in Q3
by Zacks Equity Research
The Estee Lauder Companies' (EL) third-quarter fiscal 2022 sales and earnings rise year over year on growth in every product category. Management lowered fiscal 2022 view.
Inter Parfums (IPAR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Inter Parfums (IPAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums (IPAR) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Keurig Dr Pepper (KDP) Q1 Earnings In Line, Sales Surpass
by Zacks Equity Research
Keurig Dr Pepper (KDP) reports solid sales performance for first-quarter 2022 on gains from its robust brand portfolio. KDP raises sales view for the year.
What's in Store for The Estee Lauder Companies' (EL) Q3 Earnings?
by Zacks Equity Research
The Estee Lauder Companies (EL) third-quarter fiscal 2022 performance will likely reflect solid Skin Care sales. Also, growth in online business has been a driver.
Colgate (CL) Meets Q1 Earnings Estimates, Lowers Sales View
by Zacks Equity Research
Colgate's (CL) Q1 results reflect soft bottom-line performance on higher raw material and logistics costs despite the increased top line. Margins remain soft.
What's in Store for Service Corporation (SCI) in Q1 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) first-quarter results are likely to reflect gains from increased funerals performed, whereas high costs are a concern.
Things to Note as Medifast (MED) Lines Up for Q1 Earnings
by Zacks Equity Research
Medifast's (MED) first-quarter results are likely to reflect gains from the OPTAVIA lifestyle solution and coaching support system, whereas high costs are a concern.
Helen of Troy (HELE) Q4 Earnings Top Estimates & Increase Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) fourth-quarter results reflect higher earnings and sales, including strength in the organic business and contributions from the Osprey acquisition.
Altria (MO) Q1 Earnings & Revenues Top Estimates, Pricing Aids
by Zacks Equity Research
Altria Group's (MO) first-quarter 2022 results reflect increased revenues and earnings. Pricing remains an upside, though shipment volumes appear soft.
Inter Parfums' (IPAR) Q1 Sales Solid, Brand Strength Key Driver
by Zacks Equity Research
Inter Parfums' (IPAR) sales increase year over year in first-quarter 2022. The company's largest and mid-sized brands deliver solid sales performance.
Mondelez (MDLZ) Q1 Earnings Top Estimates, Cost Woes Linger
by Zacks Equity Research
Mondelez's (MDLZ) first-quarter 2022 results reflect higher earnings and revenues, with the latter gaining on buyouts and solid organic revenues. Management expects input cost inflation to persist.
Hershey (HSY) Queued for Q1 Earnings: Things to Consider
by Zacks Equity Research
Hershey's (HSY) first-quarter 2022 performance is likely to reflect gains from prudent acquisitions and strategic pricing efforts.